Optimizing treatment selection: outcomes of radical cystectomy in patients eligible for trimodal therapy
This study examines oncological and functional outcomes in a subset of patients eligible for trimodal therapy (TMT) within a large radical cystectomy (RC) cohort. It aims to determine whether TMT should be offered to all eligible patients, rather than exclusively to patients with significant comorbi...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
29 March 2025
|
| In: |
World journal of urology
Year: 2025, Volume: 43, Issue: 1, Pages: 1-7 |
| ISSN: | 1433-8726 |
| DOI: | 10.1007/s00345-025-05566-9 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00345-025-05566-9 Verlag, lizenzpflichtig, Volltext: https://link.springer.com/article/10.1007/s00345-025-05566-9 |
| Author Notes: | Maurin Helen Mangold, Malin Nientiedt, Frank Waldbillig, Maurice Stephan Michel, Nicolas Carl, Britta Grüne, Maximilian Christian Kriegmair |
| Summary: | This study examines oncological and functional outcomes in a subset of patients eligible for trimodal therapy (TMT) within a large radical cystectomy (RC) cohort. It aims to determine whether TMT should be offered to all eligible patients, rather than exclusively to patients with significant comorbidities who are at high perioperative risk. |
|---|---|
| Item Description: | Gesehen am 08.07.2025 |
| Physical Description: | Online Resource |
| ISSN: | 1433-8726 |
| DOI: | 10.1007/s00345-025-05566-9 |